Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Subarachnoid Hemorrhage | 22 | 2021 | 1018 | 2.740 |
Why?
|
Hydrocephalus | 4 | 2021 | 748 | 1.390 |
Why?
|
Endarterectomy, Carotid | 5 | 2022 | 546 | 0.870 |
Why?
|
Vasospasm, Intracranial | 9 | 2011 | 208 | 0.730 |
Why?
|
Ventriculostomy | 2 | 2018 | 136 | 0.700 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2019 | 189 | 0.700 |
Why?
|
Drainage | 2 | 2021 | 1142 | 0.610 |
Why?
|
Cerebrovascular Disorders | 8 | 2012 | 1504 | 0.560 |
Why?
|
Intracranial Thrombosis | 2 | 2015 | 113 | 0.540 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2016 | 36 | 0.540 |
Why?
|
Intracranial Hypertension | 1 | 2018 | 186 | 0.530 |
Why?
|
Magnetic Resonance Angiography | 7 | 2016 | 1442 | 0.440 |
Why?
|
Brain Injuries | 2 | 2019 | 2025 | 0.420 |
Why?
|
Consciousness Disorders | 1 | 2016 | 418 | 0.410 |
Why?
|
Cerebrovascular Circulation | 9 | 2016 | 2731 | 0.410 |
Why?
|
Carotid Stenosis | 4 | 2022 | 854 | 0.380 |
Why?
|
Ischemic Attack, Transient | 5 | 2022 | 935 | 0.370 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.330 |
Why?
|
Intracranial Embolism | 2 | 2001 | 202 | 0.330 |
Why?
|
Nicardipine | 2 | 2008 | 60 | 0.320 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.300 |
Why?
|
Stroke | 12 | 2022 | 9981 | 0.260 |
Why?
|
Brain Ischemia | 10 | 2012 | 3265 | 0.250 |
Why?
|
Nerve Net | 1 | 2016 | 2174 | 0.240 |
Why?
|
Intracranial Aneurysm | 5 | 2017 | 1197 | 0.240 |
Why?
|
Sodium Chloride | 1 | 2006 | 625 | 0.230 |
Why?
|
Hypothermia, Induced | 2 | 2006 | 752 | 0.230 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.230 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2009 | 1373 | 0.220 |
Why?
|
Cerebral Arteries | 3 | 2002 | 494 | 0.210 |
Why?
|
Endovascular Procedures | 1 | 2015 | 1979 | 0.210 |
Why?
|
Fibrinolytic Agents | 5 | 2022 | 2158 | 0.200 |
Why?
|
Cerebral Angiography | 3 | 2005 | 1285 | 0.200 |
Why?
|
Weaning | 1 | 2021 | 105 | 0.200 |
Why?
|
Thrombolytic Therapy | 5 | 2015 | 2161 | 0.190 |
Why?
|
Phenylephrine | 2 | 2001 | 301 | 0.190 |
Why?
|
Fever | 2 | 2006 | 1616 | 0.190 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 690 | 0.190 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2021 | 194 | 0.190 |
Why?
|
Embolism, Cholesterol | 1 | 2000 | 34 | 0.190 |
Why?
|
Carotid Artery, Internal | 1 | 2003 | 445 | 0.180 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 1999 | 12 | 0.180 |
Why?
|
Dantrolene | 2 | 2011 | 26 | 0.180 |
Why?
|
Cerebral Infarction | 7 | 2005 | 1011 | 0.180 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1999 | 65 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 14 | 2015 | 20129 | 0.180 |
Why?
|
APACHE | 1 | 2000 | 277 | 0.170 |
Why?
|
Muscle Relaxants, Central | 2 | 2011 | 86 | 0.170 |
Why?
|
Treatment Outcome | 14 | 2022 | 63114 | 0.170 |
Why?
|
Intracranial Hemorrhages | 3 | 2022 | 855 | 0.170 |
Why?
|
Cerebral Veins | 1 | 1999 | 156 | 0.160 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 148 | 0.160 |
Why?
|
Clinical Competence | 1 | 2013 | 4687 | 0.150 |
Why?
|
Prospective Studies | 13 | 2022 | 53288 | 0.150 |
Why?
|
Length of Stay | 3 | 2021 | 6309 | 0.140 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1998 | 131 | 0.140 |
Why?
|
Tissue Plasminogen Activator | 3 | 2010 | 1261 | 0.140 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 2872 | 0.140 |
Why?
|
Aged | 39 | 2016 | 163280 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 16 | 2006 | 35421 | 0.130 |
Why?
|
Vasoconstrictor Agents | 2 | 2002 | 642 | 0.130 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 1996 | 141 | 0.130 |
Why?
|
Blood Glucose | 2 | 2009 | 6256 | 0.130 |
Why?
|
Spin Labels | 1 | 2016 | 332 | 0.130 |
Why?
|
Embolization, Therapeutic | 2 | 2004 | 1392 | 0.130 |
Why?
|
Phospholipases A | 2 | 1995 | 216 | 0.130 |
Why?
|
Acetates | 1 | 1996 | 311 | 0.120 |
Why?
|
Humans | 64 | 2022 | 744343 | 0.120 |
Why?
|
Amines | 1 | 1996 | 276 | 0.120 |
Why?
|
Thromboembolism | 1 | 2001 | 986 | 0.120 |
Why?
|
Insulin | 1 | 2009 | 6580 | 0.120 |
Why?
|
Male | 51 | 2016 | 350118 | 0.120 |
Why?
|
Herpes Zoster | 1 | 1996 | 264 | 0.110 |
Why?
|
Retrospective Studies | 17 | 2022 | 77449 | 0.110 |
Why?
|
Middle Aged | 39 | 2016 | 213383 | 0.110 |
Why?
|
Blood Pressure | 4 | 2012 | 8554 | 0.110 |
Why?
|
Female | 51 | 2016 | 380194 | 0.110 |
Why?
|
Patient Admission | 1 | 2000 | 1380 | 0.110 |
Why?
|
Odds Ratio | 4 | 2013 | 9849 | 0.100 |
Why?
|
Pilot Projects | 5 | 2016 | 8324 | 0.100 |
Why?
|
Postoperative Complications | 4 | 2012 | 15295 | 0.100 |
Why?
|
Adult | 30 | 2021 | 214055 | 0.100 |
Why?
|
Microsomes | 1 | 1991 | 257 | 0.100 |
Why?
|
Acute Disease | 9 | 2006 | 7149 | 0.100 |
Why?
|
Neurotoxins | 1 | 1991 | 237 | 0.090 |
Why?
|
Isoenzymes | 2 | 1995 | 1726 | 0.090 |
Why?
|
Glutamates | 1 | 1991 | 398 | 0.090 |
Why?
|
Aged, 80 and over | 15 | 2015 | 57776 | 0.090 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1996 | 1121 | 0.090 |
Why?
|
Middle Cerebral Artery | 2 | 2008 | 264 | 0.090 |
Why?
|
Neuralgia | 1 | 1996 | 570 | 0.090 |
Why?
|
Risk Adjustment | 1 | 2013 | 594 | 0.090 |
Why?
|
Brain | 11 | 2004 | 26385 | 0.080 |
Why?
|
Infusions, Intra-Arterial | 2 | 2008 | 234 | 0.080 |
Why?
|
Lipid Peroxides | 2 | 1998 | 73 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2010 | 5317 | 0.080 |
Why?
|
Arterial Occlusive Diseases | 2 | 2005 | 793 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 1991 | 822 | 0.080 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2011 | 292 | 0.070 |
Why?
|
Critical Care | 1 | 2000 | 2647 | 0.070 |
Why?
|
Pelvis | 2 | 2003 | 730 | 0.070 |
Why?
|
Diffusion | 2 | 1999 | 833 | 0.070 |
Why?
|
Nicotine | 1 | 2011 | 681 | 0.070 |
Why?
|
Headache | 2 | 2012 | 1226 | 0.070 |
Why?
|
Perfusion | 3 | 2003 | 1360 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 957 | 0.070 |
Why?
|
Databases, Factual | 2 | 2012 | 7729 | 0.070 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2006 | 105 | 0.070 |
Why?
|
Simvastatin | 1 | 2008 | 360 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2274 | 0.070 |
Why?
|
Vasoconstriction | 2 | 2011 | 597 | 0.060 |
Why?
|
Vasodilation | 1 | 2008 | 944 | 0.060 |
Why?
|
Cerebral Hemorrhage | 2 | 2006 | 2647 | 0.060 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2005 | 138 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2008 | 885 | 0.060 |
Why?
|
Embolism, Paradoxical | 1 | 2003 | 58 | 0.060 |
Why?
|
Bartonella Infections | 1 | 2003 | 22 | 0.060 |
Why?
|
Cerebral Cortex | 3 | 1998 | 5708 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 2212 | 0.050 |
Why?
|
Basilar Artery | 2 | 2005 | 200 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1622 | 0.050 |
Why?
|
Logistic Models | 4 | 2012 | 13408 | 0.050 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2006 | 500 | 0.050 |
Why?
|
Serotonin Receptor Agonists | 1 | 2002 | 152 | 0.050 |
Why?
|
Risk Factors | 9 | 2022 | 72290 | 0.050 |
Why?
|
Hypertension | 1 | 2001 | 8480 | 0.050 |
Why?
|
Stents | 1 | 2012 | 3280 | 0.050 |
Why?
|
Cholesterol Esters | 2 | 1998 | 73 | 0.050 |
Why?
|
Predictive Value of Tests | 7 | 2012 | 15076 | 0.050 |
Why?
|
Treatment Failure | 1 | 2006 | 2618 | 0.050 |
Why?
|
Rehabilitation, Vocational | 1 | 2000 | 82 | 0.050 |
Why?
|
Cytosol | 2 | 1995 | 901 | 0.050 |
Why?
|
Craniotomy | 1 | 2004 | 729 | 0.040 |
Why?
|
Seizures | 1 | 2012 | 2859 | 0.040 |
Why?
|
Cohort Studies | 4 | 2012 | 40561 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2006 | 1530 | 0.040 |
Why?
|
Catheterization, Peripheral | 1 | 2003 | 345 | 0.040 |
Why?
|
Brain Damage, Chronic | 1 | 2000 | 265 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2071 | 0.040 |
Why?
|
Veins | 1 | 2003 | 770 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1639 | 0.040 |
Why?
|
Encephalitis | 1 | 2003 | 423 | 0.040 |
Why?
|
Risk Assessment | 5 | 2012 | 23338 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1470 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 2000 | 351 | 0.040 |
Why?
|
Phlebography | 1 | 1999 | 333 | 0.040 |
Why?
|
Electroencephalography | 2 | 2012 | 6150 | 0.040 |
Why?
|
Mitochondria | 1 | 1991 | 3520 | 0.040 |
Why?
|
Differential Threshold | 1 | 1997 | 80 | 0.040 |
Why?
|
Glutamic Acid | 2 | 1995 | 1169 | 0.040 |
Why?
|
Systole | 1 | 2000 | 958 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 1999 | 339 | 0.040 |
Why?
|
Thrombophlebitis | 1 | 1998 | 309 | 0.040 |
Why?
|
Status Epilepticus | 1 | 2003 | 444 | 0.040 |
Why?
|
Registries | 1 | 2012 | 8089 | 0.040 |
Why?
|
Nuclear Family | 1 | 1998 | 318 | 0.040 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 18 | 0.040 |
Why?
|
Bulbar Palsy, Progressive | 1 | 1996 | 10 | 0.040 |
Why?
|
Cranial Nerve Injuries | 1 | 1996 | 25 | 0.040 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 76 | 0.040 |
Why?
|
Blood Coagulation Disorders | 1 | 1999 | 337 | 0.040 |
Why?
|
Autopsy | 1 | 2000 | 1020 | 0.030 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 1997 | 92 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 1997 | 354 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18370 | 0.030 |
Why?
|
Phospholipases A2 | 2 | 1995 | 203 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2000 | 643 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 1995 | 668 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 1997 | 326 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2003 | 1239 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2000 | 804 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2004 | 2737 | 0.030 |
Why?
|
Heart Diseases | 3 | 2004 | 2788 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1996 | 286 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2000 | 2418 | 0.030 |
Why?
|
Prognosis | 5 | 2006 | 29063 | 0.030 |
Why?
|
Neurons | 2 | 1995 | 9338 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3255 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1998 | 1850 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 1998 | 477 | 0.030 |
Why?
|
Family Health | 1 | 1998 | 1282 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 181 | 0.030 |
Why?
|
Safety | 1 | 1997 | 1186 | 0.030 |
Why?
|
Hot Temperature | 2 | 2004 | 1354 | 0.030 |
Why?
|
Cause of Death | 2 | 2000 | 3584 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2012 | 205 | 0.030 |
Why?
|
Gerbillinae | 1 | 1991 | 89 | 0.030 |
Why?
|
Aneurysm, Ruptured | 1 | 1997 | 452 | 0.030 |
Why?
|
Cycloheximide | 1 | 1991 | 347 | 0.020 |
Why?
|
Dactinomycin | 1 | 1991 | 318 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1026 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1991 | 424 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1995 | 2557 | 0.020 |
Why?
|
Reperfusion | 1 | 1991 | 284 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1991 | 1581 | 0.020 |
Why?
|
Anticonvulsants | 2 | 1996 | 1916 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1591 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2000 | 2073 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2022 | 3068 | 0.020 |
Why?
|
Electrocardiography | 2 | 2000 | 6442 | 0.020 |
Why?
|
Radiation Injuries | 1 | 1996 | 1180 | 0.020 |
Why?
|
Liver Transplantation | 1 | 1999 | 2119 | 0.020 |
Why?
|
Boston | 2 | 2012 | 9313 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2000 | 11727 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2011 | 5078 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1999 | 2148 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1991 | 1572 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10252 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2006 | 33 | 0.020 |
Why?
|
Sensitivity and Specificity | 4 | 2003 | 14722 | 0.020 |
Why?
|
Causality | 2 | 2003 | 1275 | 0.020 |
Why?
|
Shivering | 1 | 2004 | 11 | 0.020 |
Why?
|
Paresis | 1 | 2006 | 179 | 0.020 |
Why?
|
Meperidine | 1 | 2004 | 38 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1525 | 0.020 |
Why?
|
Neurologic Examination | 2 | 1999 | 930 | 0.020 |
Why?
|
Echocardiography | 3 | 2003 | 5102 | 0.020 |
Why?
|
Carcinoma | 1 | 1996 | 2375 | 0.020 |
Why?
|
Skin Temperature | 1 | 2004 | 93 | 0.020 |
Why?
|
Ascorbic Acid | 2 | 1998 | 651 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 2126 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2008 | 977 | 0.010 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15540 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.010 |
Why?
|
Buspirone | 1 | 2004 | 82 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
Kinetics | 1 | 1991 | 6473 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 802 | 0.010 |
Why?
|
Dementia | 1 | 1997 | 2518 | 0.010 |
Why?
|
Comorbidity | 2 | 2010 | 10388 | 0.010 |
Why?
|
Epilepsy | 1 | 1998 | 3310 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2005 | 1420 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 20947 | 0.010 |
Why?
|
Contrast Media | 2 | 2008 | 5300 | 0.010 |
Why?
|
Ephedrine | 1 | 2002 | 54 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2759 | 0.010 |
Why?
|
RNA | 1 | 1991 | 2749 | 0.010 |
Why?
|
Cell Survival | 1 | 1991 | 5882 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 21683 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2004 | 440 | 0.010 |
Why?
|
Body Temperature | 1 | 2004 | 777 | 0.010 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 478 | 0.010 |
Why?
|
Algorithms | 1 | 2001 | 13881 | 0.010 |
Why?
|
Time Factors | 5 | 2002 | 40075 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 758 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2003 | 39050 | 0.010 |
Why?
|
Cells, Cultured | 2 | 1995 | 19229 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 32 | 0.010 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
Rats | 2 | 1995 | 24260 | 0.010 |
Why?
|
Hemodynamics | 2 | 2000 | 4199 | 0.010 |
Why?
|
Quality of Life | 1 | 2000 | 12804 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2002 | 1590 | 0.010 |
Why?
|
Social Adjustment | 1 | 2000 | 631 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 2593 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1991 | 7722 | 0.010 |
Why?
|
Blood Volume | 1 | 1999 | 565 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12959 | 0.010 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 1997 | 89 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6622 | 0.010 |
Why?
|
Neck Muscles | 1 | 1996 | 104 | 0.010 |
Why?
|
Cranial Nerves | 1 | 1996 | 101 | 0.010 |
Why?
|
Calcimycin | 1 | 1995 | 222 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2006 | 2795 | 0.010 |
Why?
|
Ubiquinone | 1 | 1997 | 188 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1996 | 145 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5985 | 0.010 |
Why?
|
Survival Rate | 2 | 2000 | 12788 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3912 | 0.010 |
Why?
|
Speech Disorders | 1 | 1996 | 189 | 0.010 |
Why?
|
Neck Injuries | 1 | 1996 | 152 | 0.010 |
Why?
|
Echo-Planar Imaging | 1 | 1999 | 659 | 0.010 |
Why?
|
Cachexia | 1 | 1996 | 204 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1995 | 821 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12026 | 0.010 |
Why?
|
Animals | 4 | 2000 | 168757 | 0.010 |
Why?
|
Lung Diseases | 1 | 2004 | 1886 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1997 | 1144 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 3527 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2000 | 1827 | 0.010 |
Why?
|
Disease Progression | 2 | 1999 | 13284 | 0.010 |
Why?
|
Vitamin E | 1 | 1997 | 869 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2187 | 0.010 |
Why?
|
Electromyography | 1 | 1996 | 1379 | 0.010 |
Why?
|
Uric Acid | 1 | 1997 | 766 | 0.010 |
Why?
|
Recovery of Function | 1 | 2001 | 2925 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9687 | 0.010 |
Why?
|
Deglutition Disorders | 1 | 1996 | 605 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 1996 | 763 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1995 | 3701 | 0.010 |
Why?
|
Antioxidants | 1 | 1997 | 1663 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 1999 | 2268 | 0.010 |
Why?
|
Dyspnea | 1 | 1996 | 1303 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8642 | 0.000 |
Why?
|
Heart | 1 | 2000 | 4467 | 0.000 |
Why?
|
Models, Statistical | 1 | 2001 | 5102 | 0.000 |
Why?
|
Pregnancy | 1 | 2006 | 29144 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19905 | 0.000 |
Why?
|
Calcium | 1 | 1995 | 5756 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2000 | 18029 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 1997 | 8037 | 0.000 |
Why?
|
United States | 1 | 2003 | 69872 | 0.000 |
Why?
|
Adolescent | 1 | 2003 | 85781 | 0.000 |
Why?
|
Heart Failure | 1 | 1999 | 10900 | 0.000 |
Why?
|